The United States and Europe are drugmakers' biggest markets, but just because a drug wins approval in one doesn't mean it will get the nod in the other. Each market has its own system for clinical trials and drug reviews, and there are key differences in commercializing drugs in these regions that investors ought to know about before investing.
How Drug Approvals in Europe Are Different Than in the United States
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться